Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

Clinical trial NCT05087056 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05087056
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Meningitis, Meningococcal

Start date: 2021-11-18
Primary completion: 2027-03-10
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.